Shanghai Rongtai Health Technology Corporation Limited (SHA:603579)
China flag China · Delayed Price · Currency is CNY
17.25
0.00 (0.00%)
Sep 16, 2026, 3:00 PM CST

SHA:603579 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
1,7311,5521,5751,8451,9862,586
Other Revenue
22.3121.1121.919.8718.5827.06
1,7541,5731,5971,8552,0052,613
Revenue Growth
10.83%-1.50%-13.92%-7.47%-23.26%29.30%
Cost of Revenue
1,2471,0931,0951,2941,4761,913
Gross Profit
506.49480.28502.03561.3528.47699.91
Selling, General & Admin
341.94293.09266.32277.87280.34329.02
Research & Development
102.8493.380.180.1888.66119.21
Other Operating Expenses
36.1923.126.017.77.836.27
Operating Expenses
481.43409.76355.22364.86382.33460.41
Operating Income
25.0670.52146.82196.44146.14239.5
Interest Expense
-6.59-20.42-5.9-27.41-28.79-28.74
Interest & Investment Income
95.971.1753.8864.1144.37104.76
Currency Exchange Gain (Loss)
-12.28-3.387.427.925.76-15.75
Other Non Operating Income (Expenses)
3.070.173.06-7.2-27.66-58.25
EBT Excluding Unusual Items
105.15118.06205.27233.84159.82241.52
Gain (Loss) on Sale of Investments
51.0241.14-6.14-16.2210.414.69
Gain (Loss) on Sale of Assets
0.991.730.7-0.950.151.31
Asset Writedown
-3.18-3.1-1.21-1.29-0.01-1.7
Legal Settlements
5.15.1----
Other Unusual Items
26.1121.511.3714.81915.13
Pretax Income
185.19184.42209.99230.19179.37260.96
Income Tax Expense
10.9534.4318.1926.8614.6532.93
Earnings From Continuing Operations
174.24150191.81203.33164.72228.03
Minority Interest in Earnings
3.330.710.14-0.63-0.498.3
Net Income
177.57150.7191.95202.71164.23236.34
Net Income to Common
177.57150.7191.95202.71164.23236.34
Net Income Growth
7.00%-21.49%-5.31%23.43%-30.51%22.45%
Shares Outstanding (Basic)
195182173173174176
Shares Outstanding (Diluted)
195182198173174182
Shares Change
3.01%-8.24%14.21%-0.18%-4.53%2.16%
EPS (Basic)
0.910.831.111.170.951.35
EPS (Diluted)
0.910.830.971.170.951.30
EPS Growth
3.88%-14.43%-17.09%23.65%-27.21%19.86%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-5.4162.9117.06254.69136.14196.45
Free Cash Flow Per Share
-0.030.350.091.470.781.08
Dividend Per Share
0.5000.5000.6500.7690.3850.538
Dividend Growth
42.86%-23.08%-15.50%100.00%-28.58%40.02%
Gross Margin
28.88%30.54%31.44%30.26%26.36%26.79%
Operating Margin
1.43%4.48%9.19%10.59%7.29%9.17%
Profit Margin
10.13%9.58%12.02%10.93%8.19%9.05%
Free Cash Flow Margin
-0.31%4.00%1.07%13.73%6.79%7.52%
EBITDA
78.22124.14203.83256.39204.07292.8
EBITDA Margin
4.46%7.89%12.76%13.82%10.18%11.21%
D&A For EBITDA
53.1753.6157.0159.9657.9353.3
EBIT
25.0670.52146.82196.44146.14239.5
EBIT Margin
1.43%4.48%9.19%10.59%7.29%9.17%
Effective Tax Rate
5.91%18.67%8.66%11.67%8.17%12.62%
Revenue as Reported
1,7541,5731,5971,8552,0052,613
Advertising Expenses
-140.82115.31130.36133.74180.52